CEACAM5 and colorectal carcinoma: The AUC of the combined CEA-FPR was equal to that of CEA-FPR-CA19-9, and their sensitivity and specificity were higher than those of the single biomarkers, showing that the combined CEA-FPR was superior to FPR or AFR in identifying early-stage CRC from benign colorectal polyps.